Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
$0.61
+0.0155 ( +2.60% ) 780.1K
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
Market Data
Open
$0.61
Previous close
$0.60
Volume
780.1K
Market cap
$10.66M
Day range
$0.59 - $0.62
52 week range
$0.58 - $58.88
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 57 | Dec 20, 2023 |
8-k | 8K-related | 95 | Dec 12, 2023 |
8-k | 8K-related | 13 | Dec 08, 2023 |
8-k | 8K-related | 74 | Dec 04, 2023 |
8-k | 8K-related | 118 | Nov 15, 2023 |
8-k | 8K-related | 13 | Nov 13, 2023 |
8-k | 8K-related | 13 | Nov 09, 2023 |
10-q | Quarterly Reports | 91 | Nov 09, 2023 |
8-k | 8K-related | 68 | Nov 02, 2023 |
8-k | 8K-related | 13 | Oct 31, 2023 |